Chang-Sup Lim

Papers

Total Citations

H-Index

About

Dr. Chang-Sup Lim is a leading figure in hepatobiliary and pancreatic surgery, with a focused expertise in the surgical management of gallbladder cancer (GBC). His major contribution lies in advancing minimally invasive techniques for complex oncologic resections. In a landmark multicenter, propensity score-matched study, Dr. Lim demonstrated that minimally invasive extended cholecystectomy (MI-EC)—including laparoscopic and robotic approaches—offers comparable oncologic outcomes to traditional open surgery, with the added benefits of reduced blood loss and shorter hospital stays. This work, which has already garnered significant attention, provides crucial evidence supporting the broader adoption of MI-EC for select GBC patients. By rigorously comparing surgical approaches, Dr. Lim is directly shaping clinical guidelines and improving recovery for patients facing this challenging disease. His research is instrumental in bridging the gap between surgical innovation and evidence-based practice, marking him as a key contributor to the future of minimally invasive cancer surgery.